Acquiring Company
Illumina Cambridge Limited
Acquired Company
SomaLogic
Description
Illumina Inc. has announced its agreement to acquire SomaLogic, a company focused on protein biomarker discovery. The acquisition aims to enhance Illumina's capabilities in proteomics, particularly for drug discovery and development. Illumina's Protein Prep technology, combined with SomaLogic’s innovations, is expected to streamline analysis and accelerate discoveries. This merger supports a global initiative to improve therapies for various diseases.
Other recent acquisitions in research and Health Care
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- FOXO Technologies completes acquisition of Vector Biosource (September 22, 2025)
- Precision BioLogic acquires George King Bio-Medical (October 16, 2025)
- AbbVie acquires Bretisilocin for mental health expansion (October 15, 2025)
- Primary Health Properties completes Assura takeover (October 15, 2025)
- Cortechs.ai acquires ZepMed for AI neuroimaging (October 14, 2025)
- OSR Holdings to acquire Woori IO for diabetes care (October 14, 2025)
Who to call at Illumina Cambridge Limited, and when
When Illumina Cambridge Limited changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Illumina Cambridge Limited raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Illumina Cambridge Limited, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Illumina Cambridge Limited. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Illumina Cambridge Limited makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired SomaLogic?
SomaLogic was acquired by Illumina Cambridge Limited, based in Cambridge. The deal was reported on September 3, 2025. Illumina Cambridge Limited is a subsidiary of Illumina, Inc., a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. Illumina Cambridge Limited is privately held and operates in research.
When did Illumina Cambridge Limited acquire SomaLogic?
Illumina Cambridge Limited's acquisition of SomaLogic was reported on September 3, 2025. Illumina Inc. has announced its agreement to acquire SomaLogic, a company focused on protein biomarker discovery. The acquisition aims to enhance Illumina's capabilities in proteomics, particularly for drug discovery and development. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does SomaLogic do?
SomaLogic (Nasdaq: SLGC) seeks to deliver precise, meaningful, and actionable health-management information that empowers individuals worldwide to continuously optimize their personal health and wellness throughout their lives. It is privately held, operating in Information Technology, and is based in Boulder.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.